atropine has been researched along with vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)- in 13 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)-) | Trials (vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)-) | Recent Studies (post-2010) (vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)-) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 53 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henning, RJ | 1 |
| Holmes, EP; O'Malley, NA; Venugopalan, CS | 1 |
| Lenz, HJ; Rivier, JE; Vale, WW | 1 |
| Kantoh, M; Kusunoki, M; Takahashi, T; Utsunomiya, J; Yamamura, T | 1 |
| Chang, F; Chevalier, P; Cohen, IS; Danilo, P; Rosen, MR; Shvilkin, A | 1 |
| Applegate, RJ; Xenopoulos, NP | 1 |
| Barrett, J; McDougall, JJ; Morrison, JD | 1 |
| Coers, CM; Feliciano, L; Henning, RJ | 1 |
| Feliciano, L; Henning, RJ | 1 |
| Giralt, M; Vergara, P | 1 |
| Bianciotti, LG; Corbo, NS; Rodríguez, MR; Sabbatini, ME; Vatta, MS | 1 |
| Bornstein, JC; Larsson, MH; Lindström, E; Sapnara, M; Sjövall, H; Svensson, DJ; Thomas, EA | 1 |
| Capouch, J; Faitová, S; Kuncová, J; Slavíková, J; Stengl, M | 1 |
13 other study(ies) available for atropine and vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)-
| Article | Year |
|---|---|
Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate.
Topics: Animals; Atropine; Dogs; Electric Stimulation; Heart Atria; Heart Rate; Myocardial Contraction; Propranolol; Vagus Nerve; Vasoactive Intestinal Peptide | 1992 |
Evidence for vasoactive intestinal peptide as a mediator of non-adrenergic non-cholinergic neurotransmission in the trachea.
Topics: Animals; Atropine; Dose-Response Relationship, Drug; Electric Stimulation; Growth Hormone-Releasing Hormone; Guinea Pigs; Male; Muscle Relaxation; Muscle, Smooth; Propranolol; Receptors, Adrenergic; Receptors, Cholinergic; Sermorelin; Synaptic Transmission; Trachea; Vagus Nerve; Vasoactive Intestinal Peptide | 1990 |
TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways.
Topics: Animals; Atropine; beta-Endorphin; Bicarbonates; Brain; Carbachol; Chlorisondamine; Dose-Response Relationship, Drug; Duodenum; Injections, Intravenous; Injections, Intraventricular; Male; Muscarine; Neurotensin; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone; Vagus Nerve; Vasoactive Intestinal Peptide | 1989 |
Different innervation mechanisms between the lesser and greater curvature of guinea pig antrum.
Topics: Animals; Apamin; Atropine; Chymotrypsin; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Phentolamine; Prazosin; Propranolol; Pyloric Antrum; Tetrodotoxin; Theophylline; Vasoactive Intestinal Peptide; Yohimbine | 1989 |
Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart.
Topics: Animals; Atropine; Electric Stimulation; Heart Rate; In Vitro Techniques; Male; Perfusion; Propranolol; Rats; Rats, Wistar; Tachycardia; Vagus Nerve; Vasoactive Intestinal Peptide | 1994 |
Effects of vasoactive intestinal peptide on myocardial performance.
Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Diastole; Dogs; Heart; Heart Rate; Hemodynamics; Infusions, Intravenous; Propranolol; Systole; Vagus Nerve; Vasoactive Intestinal Peptide; Venae Cavae | 1994 |
Enhancement by atropine of the pancreatic exocrine secretions evoked by vagal stimulation in the pithed rat.
Topics: Animals; Atropine; Bicarbonates; Decerebrate State; Electric Stimulation; Islets of Langerhans; Male; Methacholine Compounds; Pancreatic Juice; Rats; Rats, Wistar; Vagus Nerve; Vasoactive Intestinal Peptide | 1993 |
Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Dogs; Electric Stimulation; Heart Rate; Hormone Antagonists; Muscarinic Antagonists; Propranolol; Receptors, Vasoactive Intestinal Peptide; Vagus Nerve; Vasoactive Intestinal Peptide; Ventricular Function, Right | 1996 |
Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Cardiac Pacing, Artificial; Coronary Circulation; Dogs; Electric Stimulation; Female; Hormone Antagonists; Male; Muscarinic Antagonists; Nitroglycerin; Propranolol; Receptors, Vasoactive Intestinal Peptide; Vagus Nerve; Vasoactive Intestinal Peptide; Vasodilator Agents | 1998 |
Inhibition by CCK of ascending contraction elicited by mucosal stimulation in the duodenum of the rat.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Benzodiazepinones; Cholecystokinin; Depression, Chemical; Devazepide; Duodenum; Electric Stimulation; Enteric Nervous System; Enzyme Inhibitors; Gastrins; Hexamethonium; Intestinal Mucosa; Male; Muscle Contraction; Nicotinic Antagonists; Nitroarginine; Oligopeptides; Parasympatholytics; Peristalsis; Phentolamine; Phenylurea Compounds; Propranolol; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Vasoactive Intestinal Peptide; Sincalide; Tetragastrin; Vasoactive Intestinal Peptide | 2000 |
C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
Topics: Animals; Atrial Natriuretic Factor; Atropine; Brain; Cyclic GMP; Drug Interactions; Enzyme Inhibitors; Ganglionic Blockers; Hexamethonium; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pancreas; Parasympatholytics; Peptide Fragments; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Secretin; Sincalide; Thionucleotides; Time Factors; Vagotomy; Vagus Nerve; Vasoactive Intestinal Peptide | 2005 |
Pharmacological analysis of components of the change in transmural potential difference evoked by distension of rat proximal small intestine in vivo.
Topics: Anesthetics, Local; Animals; Atropine; Chlorides; Colon; Duodenum; Enzyme Inhibitors; Ganglionic Blockers; Granisetron; Hexamethonium; Hormone Antagonists; Injections, Intravenous; Intestinal Secretions; Lidocaine; Male; Mechanotransduction, Cellular; Membrane Potentials; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Neurokinin-1 Receptor Antagonists; Nitric Oxide Synthase; Nitroarginine; Peripheral Nervous System Agents; Piperidines; Pressure; Quinolines; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Receptors, Serotonin, 5-HT3; Receptors, Vasoactive Intestinal Peptide; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tetrodotoxin; Time Factors; Vasoactive Intestinal Peptide | 2008 |
Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Electric Stimulation; Heart Atria; Heart Rate; Hormone Antagonists; Metipranolol; Muscarinic Antagonists; Phentolamine; Rats; Rats, Wistar; Receptors, Muscarinic; Time Factors; Vagus Nerve; Vasoactive Intestinal Peptide | 2008 |